These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35810923)

  • 41. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
    Runegaard AH; Dencker D; Wörtwein G; Gether U
    Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in an NMDA, AMPA/kainate, and metabotropic glutamate receptor-dependent manner.
    Suto N; Tanabe LM; Austin JD; Creekmore E; Vezina P
    Neuropsychopharmacology; 2003 Apr; 28(4):629-39. PubMed ID: 12655307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.
    Prieto-Gómez B; Vázquez-Alvarez AM; Martínez-Peña JL; Reyes-Vázquez C; Yang PB; Dafny N
    Life Sci; 2005 Jun; 77(6):635-49. PubMed ID: 15921995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prenatal ethanol exposure increases risk of psychostimulant addiction.
    Wang R; Shen YL; Hausknecht KA; Chang L; Haj-Dahmane S; Vezina P; Shen RY
    Behav Brain Res; 2019 Jan; 356():51-61. PubMed ID: 30076855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amphetamine acts within the lateral hypothalamic area to elicit affectively neutral arousal and reinstate drug-seeking.
    Schmeichel BE; Berridge CW
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):63-75. PubMed ID: 23895988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid.
    Chou YH; Hor CC; Lee MT; Lee HJ; Guerrini R; Calo G; Chiou LC
    Addict Biol; 2021 May; 26(3):e12971. PubMed ID: 33078457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amphetamine self-administration attenuates dopamine D2 autoreceptor function.
    Calipari ES; Sun H; Eldeeb K; Luessen DJ; Feng X; Howlett AC; Jones SR; Chen R
    Neuropsychopharmacology; 2014 Jul; 39(8):1833-42. PubMed ID: 24513972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice.
    Ledesma JC; Manzanedo C; Aguilar MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110390. PubMed ID: 34157334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.
    Razavi Y; Keyhanfar F; Shabani R; Haghparast A; Mehdizadeh M
    Iran J Pharm Res; 2021; 20(4):152-164. PubMed ID: 35194436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
    Cancela LM; Basso AM; Martijena ID; Capriles NR; Molina VA
    Brain Res; 2001 Aug; 909(1-2):179-86. PubMed ID: 11478934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.
    Velazquez-Sanchez C; Ferragud A; Renau-Piqueras J; Canales JJ
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):655-65. PubMed ID: 20735880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabidiol (CBD) reduces cocaine-environment memory in mice.
    Chesworth R; Karl T
    Pharmacol Biochem Behav; 2020 Dec; 199():173065. PubMed ID: 33127382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus.
    Luján MÁ; Castro-Zavala A; Alegre-Zurano L; Valverde O
    Neuropharmacology; 2018 Dec; 143():163-175. PubMed ID: 30273593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topiramate-chitosan nanoparticles prevent morphine reinstatement with no memory impairment: Dopaminergic and glutamatergic molecular aspects in rats.
    Milanesi LH; Rossato DR; Oliveira da Rosa JL; D'avila LF; Metz VG; Wolf JF; Reis VB; de Andrade DF; Jank L; Beck RCR; da Silva CB; Burger ME
    Neurochem Int; 2021 Nov; 150():105157. PubMed ID: 34390773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroprotective effects of melatonin on amphetamine-induced dopaminergic fiber degeneration in the hippocampus of postnatal rats.
    Leeboonngam T; Pramong R; Sae-Ung K; Govitrapong P; Phansuwan-Pujito P
    J Pineal Res; 2018 Apr; 64(3):. PubMed ID: 29149481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ferulic acid-loaded nanostructure prevents morphine reinstatement: the involvement of dopamine system, NRF2, and ΔFosB in the striatum brain area of rats.
    Milanesi LH; Rossato DR; Rosa JLO; D'avila LF; Metz VG; Rampelotto CR; Pereira VG; Schaffazick SR; de Bona da Silva C; Burger ME
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1535-1545. PubMed ID: 36790483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine.
    Tolliver BK; Ho LB; Fox LM; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):38-47. PubMed ID: 10086985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of neonatal tactile stimulation on amphetamine preference in young rats: parameters of addiction and oxidative stress.
    Antoniazzi CT; Boufleur N; Dolci G; Roversi K; Kuhn F; Pase CS; Dias VT; Roversi K; Barcelos R; Benvegnú DM; Bürger ME
    Pharmacol Biochem Behav; 2014 Sep; 124():341-9. PubMed ID: 25019651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine.
    Tournier BB; Steimer T; Millet P; Moulin-Sallanon M; Vallet P; Ibañez V; Ginovart N
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1819-34. PubMed ID: 23574629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stress and withdrawal from d-amphetamine alter 5-HT2A receptor mRNA expression in the prefrontal cortex.
    Murray RC; Hebbard JC; Logan AS; Vanchipurakel GA; Gilbert YE; Horner KA
    Neurosci Lett; 2014 Jan; 559():44-9. PubMed ID: 24287377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.